[{"Assets_0_Q2_USD":47809000000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_2_Q2_shares":911600000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q2_shares":910400000.0,"StockholdersEquityConverted_0_Q2_USD":6663500000.0,"StockholdersEquity_0_Q2_USD":6444400000.0,"RevenuesConverted_2_Q2_USD":13545700000.0,"RevenuesConverted_1_Q2_USD":6740100000.0,"NetIncomeLossConverted_1_Q2_USD":1390200000.0,"NetIncomeLossConverted_2_Q2_USD":2745500000.0,"NetCashProvidedByUsedInOperatingActivitiesConverted_2_Q2_USD":3472900000.0,"EarningsPerShareDiluted_2_Q2_USD":3.01,"EarningsPerShareDiluted_1_Q2_USD":1.53,"EarningsPerShareBasic_2_Q2_USD":3.02,"EarningsPerShareBasic_1_Q2_USD":1.53,"CommonStockDividendsPerShareDeclared_2_Q2_USD":1.7,"CommonStockDividendsPerShareDeclared_1_Q2_USD":1.7,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":907300000.0,"WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":908200000.0,"Ticker":"LLY","CIK":"59478","name":"ELI LILLY & CO","OfficialName":"Eli Lilly and Company Common Stock","form":"10-Q","period":"20210630","fy":"2021.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"282857000000.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NYSE","SP500":"SP500","filed":"20210803"}]